ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

July 10, 2020

Progression and survival of patients with motor neuron disease relative to their fecal microbiota

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Shyuan T NgoFrederik J Steyn
July 12, 2020

Evaluation of clinical outcome and safety profile of edaravone in treatment of amyotrophic lateral sclerosis: a 72-week single-center experience

Acta neurologica Belgica
Ismail Ibrahim IsmailJasem Youssef Al-Hashel
July 11, 2020

A prospective harmonized multicentre DTI study of cerebral white matter degeneration in ALS

Neurology
Sanjay KalraJan Kassubek
July 9, 2020

Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE

Journal of Neurology
Marta GromichoMamede De Carvalho
July 9, 2020

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

Journal of Cardiovascular Pharmacology
Zoltán PappPiero Pollesello
July 9, 2020
Review

Modern approaches in gene therapy of motor neuron diseases

Medicinal Research Reviews
Maria Zakharova
July 13, 2020

Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study

NeuroImage. Clinical
Akila WeerasekeraUwe Himmelreich
July 9, 2020
Open Access

A proof-of-concept study of extracting patient histories for rare/intractable diseases from social media

Genomics & Informatics
Atsuko Yamaguchi, Núria Queralt-Rosinach
July 9, 2020
Open Access

Base editing with high efficiency in allotetraploid oilseed rape by A3A-PBE base editing system

Plant Biotechnology Journal
Hongtao ChengQiong Hu
July 9, 2020

Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis

Aging
Jordan M WilkinsClaudia F Lucchinetti
July 9, 2020

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

The New England Journal of Medicine
Timothy MillerToby A Ferguson
July 9, 2020
Review
Open Access

Neurovascular Inflammaging in Health and Disease

Cells
Ádám MészárosIstván A Krizbai
July 12, 2020

Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease

American Journal of Speech-language Pathology
Nicole M Rogus-Pulia, Emily K Plowman
July 8, 2020

Neurology Grand Rounds Complications from "Stem Cell Tourism" in Neurology

Annals of Neurology
Katherine JulianJaime Imitola
July 11, 2020

Expression of Mutant Ubiquitin and Proteostasis Impairment in Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex Brains

Journal of Neuropathology and Experimental Neurology
Bert M VerheijenFred W van Leeuwen

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/als/129bed18-9c32-4b85-ab86-f364b8288d99